| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $25.2M | — | -31.6% |
| SG&A Expense | $5.7M | — | -5.2% |
| Operating Income | -$30.9M | — | +27.9% |
| Pre-tax Income | -$33.4M | — | +22.8% |
| Income Tax | $0 | — | — |
| Net Income | -$33.4M | — | +22.8% |
| EPS (Basic) | -$2.15 | — | +23.2% |
| EPS (Diluted) | -$2.15 | — | +23.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $161.7M | +30.1% | -25.3% |
| Current Assets | $171.3M | +29.0% | -23.3% |
| Total Assets | $184.0M | +25.6% | -24.2% |
| Current Liabilities | $26.5M | -21.6% | -39.2% |
| Long-term Debt | $175.0M | +74.0% | +77.4% |
| Total Liabilities | $205.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$38.0M | — | -5.9% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $75.5M | — | -24.4% |
| Free Cash Flow | -$38.0M | — | -5.9% |
| +38.3% |
| Stockholders' Equity | -$21.0M | -363.2% | -122.3% |